¼¼¹Ì³ª/Çà»ç

> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç

Á¦¸ñ 2020³â 4¿ù 14ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2020-04-08

¼­¿ï´ëÇб³ »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿­°íÀÚ ÇÏ¿À´Ï ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.

¼¼¹Ì³ª´Â ZoomÀ» ÅëÇÑ ¿Â¶óÀÎ °­ÀÇ·Î ¿¹Á¤µÇ¾î ÀÖÀ¸¸ç °­ÀÇ¿¡ Âü¿©ÇÏ°íÀÚ ÇϽô ºÐ²²¼­´Â¡¡ mari911@snu.ac.kr·Î ¸ÞÀÏ ÁÖ½Ã¸é °­ÀÇ ¸µÅ© Àü´Þµå¸®µµ·Ï ÇÏ°Ú½À´Ï´Ù.¡¡


ÀϽÃ:¡¡¡¡2020³â 4¿ù 14ÀÏ¡¡È­¿äÀÏ ¿ÀÀü 11½Ã

¿¬»ç:¡¡¡¡¹éÈ¿Á¤ ¿¬»ç´Ô¡¡(KISTI)


TITLE

Scalable research in KISTI: Tracing millions of patients for precision medicine


Abstract

The identification of novel disease associations using big-data for patient care has had limited success. In¡¡this study, we created a longitudinal disease network of traced readmissions (disease trajectories), merging¡¡data from over 10.4 million inpatients through the Healthcare Cost and Utilization Project, which allowed¡¡the representation of disease progression mapping of over 300 diseases. From these disease trajectories, we¡¡discovered an interesting association between schizophrenia and rhabdomyolysis, a rare muscle disease¡¡(incidence <1E-04) (relative risk, 2.21 [1.80–2.71, confidence interval = 0.95] P-value 9.54E-15). We¡¡validated this association by using independent electronic medical records from over 830,000 patients at the¡¡University of California, San Francisco (UCSF) medical center. A case review of 29 rhabdomyolysis¡¡incidents in schizophrenia patients at UCSF demonstrated that 62% are idiopathic, without the use of any¡¡drug known to lead to this adverse event, suggesting a warning to physicians to watch for this unexpected¡¡risk of schizophrenia. Large-scale analysis of disease trajectories can help physicians understand potential¡¡sequential events in their patients.